• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫辛酸可能保护糖尿病患者免受 COVID-19 感染。

Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.

机构信息

Department of Internal Medicine, Ota&Jinemed Hospital, Istanbul, Turkey. Electronic address: https://orcid.org/0000-0001-7807-135X.

Department of Biochemistry, Private Practice, Istanbul, Turkey.

出版信息

Med Hypotheses. 2020 Oct;143:110185. doi: 10.1016/j.mehy.2020.110185. Epub 2020 Aug 14.

DOI:10.1016/j.mehy.2020.110185
PMID:33017914
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7427590/
Abstract

COVID-19 pandemic is spreading rapidly worldwide, and drug selection can affect the morbidity and mortality of the disease positively or negatively. Alpha-lipoic acid (ALA) is a potent antioxidant and reduces oxidative stress and inhibits activation of nuclear factor-kappa B (NF-kB). ALA reduces ADAM17 activity and ACE2 upregulation. ALA is known to have antiviral effects against some viruses. ALA may show antiviral effect by reducing NF-kB activation and alleviating redox reactions. ALA increases the intracellular glutathione strengthens the human host defense. ALA activates ATP dependent K channels (Na, K-ATPase). Increased K in the cell raises the intracellular pH. As the intracellular pH increases, the entry of the virus into the cell decreases. ALA can increase human host defense against SARS-CoV-2 by increasing intracellular pH. ALA treatment increases antioxidant levels and reduces oxidative stress. Thus, ALA may strengthen the human host defense against SARS-CoV-2 and can play a vital role in the treatment of patients with critically ill COVID-19. It can prevent cell damage by decreasing lactate production in patients with COVID-19. Using ALA with insulin in patients with diabetes can show a synergistic effect against SARS-CoV-2. We think ALA treatment will be beneficial against COVID-19 in patients with diabetes.

摘要

新冠疫情在全球迅速蔓延,药物选择可能会对疾病的发病率和死亡率产生积极或消极的影响。α-硫辛酸(ALA)是一种有效的抗氧化剂,可以降低氧化应激并抑制核因子-κB(NF-κB)的激活。ALA 可以降低 ADAM17 的活性和 ACE2 的上调。ALA 已知对某些病毒具有抗病毒作用。ALA 可能通过抑制 NF-κB 激活和减轻氧化还原反应来显示抗病毒作用。ALA 增加细胞内谷胱甘肽,增强人体宿主防御。ALA 激活 ATP 依赖性 K 通道(Na、K-ATPase)。细胞内钾的增加会提高细胞内 pH 值。随着细胞内 pH 值的升高,病毒进入细胞的数量减少。ALA 通过增加细胞内 pH 值来增加人体对 SARS-CoV-2 的宿主防御。ALA 治疗可以增加抗氧化剂水平并减少氧化应激。因此,ALA 可能增强人体对 SARS-CoV-2 的宿主防御,并在治疗重症 COVID-19 患者方面发挥重要作用。它可以通过减少 COVID-19 患者的乳酸产生来防止细胞损伤。糖尿病患者联合使用胰岛素和 ALA 可能会对 SARS-CoV-2 产生协同作用。我们认为,ALA 治疗将对糖尿病患者的 COVID-19 有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dd6/7427590/8757483fffa5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dd6/7427590/8757483fffa5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dd6/7427590/8757483fffa5/gr1_lrg.jpg

相似文献

1
Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.硫辛酸可能保护糖尿病患者免受 COVID-19 感染。
Med Hypotheses. 2020 Oct;143:110185. doi: 10.1016/j.mehy.2020.110185. Epub 2020 Aug 14.
2
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies.通过 ACE2/TMPRSS2 途径抑制 SARS-CoV-2 进入:揭示 COVID-19 早期药物治疗方法的有希望的途径。
Eur J Clin Pharmacol. 2020 Dec;76(12):1623-1630. doi: 10.1007/s00228-020-02963-4. Epub 2020 Jul 21.
3
Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.α-硫辛酸对抗 COVID-19 感染期间心血管疾病的作用机制。
Int J Mol Sci. 2021 Jul 26;22(15):7979. doi: 10.3390/ijms22157979.
4
ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?ACE2:理解 COVID-19 严重和危急情况病理生理学的关键分子:是魔鬼还是天使?
Viruses. 2020 Apr 28;12(5):491. doi: 10.3390/v12050491.
5
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.血管紧张素转换酶 2:SARS-CoV-2 受体和肾素-血管紧张素系统的调节剂:庆祝 ACE2 发现 20 周年。
Circ Res. 2020 May 8;126(10):1456-1474. doi: 10.1161/CIRCRESAHA.120.317015. Epub 2020 Apr 8.
6
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.在新冠疫情期间,血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂可能对糖尿病患者有害。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):349-350. doi: 10.1016/j.dsx.2020.04.019. Epub 2020 Apr 15.
7
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
8
SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.严重急性呼吸综合征冠状病毒2受体血管紧张素转换酶2基因表达与肾素-血管紧张素-醛固酮系统抑制剂
Lancet Respir Med. 2020 Jun;8(6):e50-e51. doi: 10.1016/S2213-2600(20)30224-1. Epub 2020 May 13.
9
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
10
Relative Limited Impact of COVID-19 on Diabetes: A Personal View.新冠病毒病对糖尿病的相对有限影响:个人观点
J Diabetes Sci Technol. 2020 Jul;14(4):727-728. doi: 10.1177/1932296820930270. Epub 2020 May 29.

引用本文的文献

1
ADME analysis, metabolic prediction, and molecular docking of lipoic acid with SARS-CoV-2 Omicron spike protein.硫辛酸与新冠病毒奥密克戎刺突蛋白的吸收、分布、代谢和排泄(ADME)分析、代谢预测及分子对接
Sci Rep. 2025 Jul 8;15(1):24386. doi: 10.1038/s41598-025-93121-2.
2
Lipoic Acid Enhances the Defense Capability of Citrus Fruits to Blue Mold Caused by .硫辛酸增强柑橘果实对由……引起的青霉病的防御能力。 (注:原文中“由……引起”部分表述不完整)
Foods. 2025 Mar 14;14(6):987. doi: 10.3390/foods14060987.
3
Interaction of Asparagusic Acid, Asparaptines and Related Dithiolane Derivatives With Angiotensin-Converting Enzyme-2 (ACE-2): A Molecular Docking Study.

本文引用的文献

1
A Randomized, Single-Blind, Group Sequential, Active-Controlled Study to Evaluate the Clinical Efficacy and Safety of α-Lipoic Acid for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).一项随机、单盲、成组序贯、活性对照研究,旨在评估α-硫辛酸对2019冠状病毒病(COVID-19)危重症患者的临床疗效和安全性。
Front Med (Lausanne). 2022 Feb 4;8:566609. doi: 10.3389/fmed.2021.566609. eCollection 2021.
2
Comment on "Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?".关于《一种用于治疗新冠肺炎的旧疟疾药物:平稳推进还是冒险尝试?》的评论
J Neuroimmune Pharmacol. 2020 Sep;15(3):345-346. doi: 10.1007/s11481-020-09938-3. Epub 2020 Jun 25.
3
天门冬氨酸、天冬酰胺及其相关二硫戊环衍生物与血管紧张素转换酶2(ACE-2)的相互作用:一项分子对接研究。
J Biochem Mol Toxicol. 2025 Apr;39(4):e70236. doi: 10.1002/jbt.70236.
4
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.精准营养以重置长期新冠病毒感染中病毒诱导的人类代谢重编程和失调(HMRD)。
NPJ Sci Food. 2024 Mar 30;8(1):19. doi: 10.1038/s41538-024-00261-2.
5
Molecular and Therapeutic Insights of Alpha-Lipoic Acid as a Potential Molecule for Disease Prevention.α-硫辛酸作为一种潜在的疾病预防分子的分子及治疗学见解
Rev Bras Farmacogn. 2023;33(2):272-287. doi: 10.1007/s43450-023-00370-1. Epub 2023 Feb 7.
6
Effect of Alpha-Lipoic Acid Supplementation on Low-Grade Squamous Intraepithelial Lesions-Double-Blind, Randomized, Placebo-Controlled Trial.补充α-硫辛酸对低度鳞状上皮内病变的影响——双盲、随机、安慰剂对照试验
Healthcare (Basel). 2022 Dec 2;10(12):2434. doi: 10.3390/healthcare10122434.
7
COVID-19 Multi-Targeted Drug Repurposing Using Few-Shot Learning.利用少样本学习进行COVID-19多靶点药物重新利用
Front Bioinform. 2021 Jun 15;1:693177. doi: 10.3389/fbinf.2021.693177. eCollection 2021.
8
Antioxidants and clinical outcomes of patients with coronavirus disease 2019: A systematic review of observational and interventional studies.抗氧化剂与2019冠状病毒病患者的临床结局:观察性和干预性研究的系统评价
Food Sci Nutr. 2022 Sep 2;10(12):4112-25. doi: 10.1002/fsn3.3034.
9
Reactive Sulfur Compounds in the Fight against COVID-19.对抗新冠病毒中的反应性硫化合物
Antioxidants (Basel). 2022 May 26;11(6):1053. doi: 10.3390/antiox11061053.
10
Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends.低分子量合成抗氧化剂:分类、药理学特征、有效性及趋势
Antioxidants (Basel). 2022 Mar 26;11(4):638. doi: 10.3390/antiox11040638.
Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis.
新型冠状病毒肺炎(COVID-19)会通过完全不同的机制导致肌痛吗?一种假说。
Clin Rheumatol. 2020 Jul;39(7):2103-2104. doi: 10.1007/s10067-020-05178-1. Epub 2020 May 26.
4
Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis.达格列净对2019冠状病毒病感染有保护作用吗?一种假说。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):405-406. doi: 10.1016/j.dsx.2020.04.024. Epub 2020 Apr 21.
5
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.在新冠疫情期间,血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂可能对糖尿病患者有害。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):349-350. doi: 10.1016/j.dsx.2020.04.019. Epub 2020 Apr 15.
6
ADAM17 inhibition may exert a protective effect on COVID-19.ADAM17抑制可能对新型冠状病毒肺炎发挥保护作用。
Nephrol Dial Transplant. 2020 Jun 1;35(6):1071-1072. doi: 10.1093/ndt/gfaa093.
7
Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?在新冠疫情期间是否应重新考虑抗糖尿病药物?
Diabetes Res Clin Pract. 2020 May;163:108146. doi: 10.1016/j.diabres.2020.108146. Epub 2020 Apr 10.
8
Comment on "Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19".关于《血管紧张素转换酶2的器官保护作用及其对新型冠状病毒肺炎预后的影响》的评论
J Med Virol. 2020 Sep;92(9):1423-1424. doi: 10.1002/jmv.25848. Epub 2020 Jun 2.
9
Comment on Sodium-Glucose Co-Transporter 2 Inhibitors and Heart Failure.对钠-葡萄糖协同转运蛋白2抑制剂与心力衰竭的评论
Am J Cardiol. 2020 May 15;125(10):1602. doi: 10.1016/j.amjcard.2020.03.001. Epub 2020 Mar 5.
10
Potential interventions for novel coronavirus in China: A systematic review.中国新型冠状病毒潜在干预措施的系统评价。
J Med Virol. 2020 May;92(5):479-490. doi: 10.1002/jmv.25707. Epub 2020 Mar 3.